(Circulation. 1995;91:619-622.)
© 1995 American Heart Association, Inc.
Articles |
Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens From Patients With Stable and Unstable Coronary Syndromes
From the Division of Cardiology, Duke University and Durham VA Medical Centers, Durham, NC, and the Cardiovascular Biology Research Program (J.H.M.), Oklahoma Medical Research Foundation, Oklahoma City, Okla.
Correspondence to Brian H. Annex, MD, Duke University Medical Center, 508 Fulton St, Box 111A, Durham, NC 27705.
Background Tissue factor (TF) is a cell membrane–associated protein that catalyzes the rate-limiting step of the extrinsic coagulation pathway, which is the major source of thrombin production in vivo. To explore the potential role that TF may play in ischemic coronary syndromes, directional coronary atherectomy specimens were tested for the presence of TF protein using immunohistochemical techniques.
Methods and Results Frozen sections from atherectomy specimens in 61 patients were examined for TF expression using an IgG murine monoclonal antibody against human TF. Patients were classified according to their admission diagnosis as having either an unstable or a stable coronary syndrome. An unstable coronary syndrome was defined as either angina pectoris occurring at rest or post–myocardial infarction (<1 week) angina. Stable coronary syndromes included patients with stable, progressive, and new-onset (<6 weeks) angina without rest pain. TF was detected in 15 (43%) of 35 patients with unstable coronary syndromes versus only 3 (12%) of 26 patients with stable coronary syndromes (odds ratio, 5.7; 95% confidence interval, 1.3 to 24.3; P=.018). Within the subgroup of patients with unstable coronary syndromes, TF was detected in 14 (60%) of 25 patients with de novo lesions versus only 1 (10%) of 10 patients with a restenosis lesion (P<.02). An additional 8 patients with stable coronary syndromes due to a restenosis lesion were also negative for TF. Therefore, the overall incidence of TF expression was only 6% (1 of 18) in restenosis lesions compared with 33% (14 of 43) in de novo lesions (P<.03).
Conclusions This study provides the first description of TF protein expression in human coronary artery lesions in vivo. Tissue factor was readily detected in de novo lesions in patients with unstable coronary syndromes, suggesting a role for TF in the pathogenesis of this disease process. Conversely, TF was rarely detected in patients with restenosis lesions even if the resulting clinical presentation was an unstable coronary syndrome. These results may have implications for the management of patients with unstable angina from de novo lesions and patients with ischemic symptoms from a restenosis lesion.
Key Words: angioplasty • thrombosis • angina • stenosis
This article has been cited by other articles:
 |
|
 |
|
  N. Mackman and M. B. Taubman Does Tissue Factor Expression by Vascular Smooth Muscle Cells Provide a Link Between C-Reactive Protein and Cardiovascular Disease? Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 601 - 603. [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C. M. Matter, Z. Yang, T. F. Luscher, et al. Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents Circulation, October 3, 2006; 114(14): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Tilley, B. Pedersen, R. Pawlinski, Y. Sato, J. H. Erlich, Y. Shen, S. Day, Y. Huang, D. T. Eitzman, W. A. Boisvert, et al. Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 555 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steffel, T. F. Luscher, and F. C. Tanner Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications Circulation, February 7, 2006; 113(5): 722 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malarstig, T. Tenno, N. Johnston, B. Lagerqvist, T. Axelsson, A.-C. Syvanen, L. Wallentin, and A. Siegbahn Genetic Variations in the Tissue Factor Gene Are Associated With Clinical Outcome in Acute Coronary Syndrome and Expression Levels in Human Monocytes Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2667 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cirillo, P. Golino, P. Calabro, G. Cali, M. Ragni, S. De Rosa, G. Cimmino, M. Pacileo, R. De Palma, L. Forte, et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation Cardiovasc Res, October 1, 2005; 68(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Morrow, S. A. Murphy, C. H. McCabe, N. Mackman, H. C. Wong, E. M. Antman, and on behalf of the PROXIMATE-TIMI 27 Investigators Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial Eur. Heart J., April 1, 2005; 26(7): 682 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mackman Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1015 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Viswambharan, X.-F. Ming, S. Zhu, A. Hubsch, P. Lerch, G. Vergeres, S. Rusconi, and Z. Yang Reconstituted High-Density Lipoprotein Inhibits Thrombin-Induced Endothelial Tissue Factor Expression Through Inhibition of RhoA and Stimulation of Phosphatidylinositol 3-Kinase but not Akt/Endothelial Nitric Oxide Synthase Circ. Res., April 16, 2004; 94(7): 918 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Golino, A. Ravera, M. Ragni, P. Cirillo, O. Piro, and M. Chiariello Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary Syndromes Circulation, December 9, 2003; 108(23): 2864 - 2869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Levi, T. T Keller, E. van Gorp, and H. ten Cate Infection and inflammation and the coagulation system Cardiovasc Res, October 15, 2003; 60(1): 26 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Jeanpierre, T. Le Tourneau, I. Six, C. Zawadzki;, E. Van Belle, M. D. Ezekowitz, R. Bordet, S. Susen, B. Jude, and D. Corseaux Dietary Lipid Lowering Modifies Plaque Phenotype in Rabbit Atheroma After Angioplasty: A Potential Role of Tissue Factor Circulation, October 7, 2003; 108(14): 1740 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Nusz, D. C. White, Q. Dai, A. M. Pippen, M. A. Thompson, G. B. Walton, C. J. Parsa, W. J. Koch, and B. H. Annex Vascular rarefaction in peripheral skeletal muscle after experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1554 - H1562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Tousoulis, G Davies, C Stefanadis, P Toutouzas, and J A Ambrose Inflammatory and thrombotic mechanisms in coronary atherosclerosis Heart, September 1, 2003; 89(9): 993 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D'Andrea, M. Ravera, P. Golino, A. Rosica, M. De Felice, M. Ragni, P. Cirillo, F. Vigorito, N. Corcione, P. Tommasini, et al. Induction of Tissue Factor in the Arterial Wall During Recurrent Thrombus Formation Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1684 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sambola, J. Osende, J. Hathcock, M. Degen, Y. Nemerson, V. Fuster, J. Crandall, and J. J. Badimon Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity Circulation, February 25, 2003; 107(7): 973 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Z. Cui, G. Zhao, A. L. Winokur, E. Laag, J. R. Bydash, M. S. Penn, G. M. Chisolm, and X. Xu Lysophosphatidic Acid Induction of Tissue Factor Expression in Aortic Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 224 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Wilcox, S. Noguchi, and J. Casanova Extrahepatic Synthesis of Factor VII in Human Atherosclerotic Vessels Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 136 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Dai, M. A Thompson, A. M Pippen, H. Cherwek, D. A Taylor, and B. H Annex Alterations in endothelial cell proliferation and apoptosis contribute to vascular remodeling following hind-limb ischemia in rabbits Vascular Medicine, May 1, 2002; 7(2): 87 - 91. [Abstract] [PDF]
|
|
|
|
 |
|
 B. D. Duscha, B. H. Annex, H. J. Green, A. M. Pippen, and W. E. Kraus Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1170 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H.M Moons, M. Levi, and R. J.G Peters Tissue factor and coronary artery disease Cardiovasc Res, February 1, 2002; 53(2): 313 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ardissino, P. A. Merlini, K. A. Bauer, E. Bramucci, M. Ferrario, R. Coppola, R. Fetiveau, S. Lucreziotti, R. D. Rosenberg, and P. M. Mannucci Thrombogenic potential of human coronary atherosclerotic plaques Blood, November 1, 2001; 98(9): 2726 - 2729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Golino, P. Cirillo, P. Calabro', M. Ragni, D. D'Andrea, E. V. Avvedimento, F. Vigorito, N. Corcione, F. Loffredo, and M. Chiariello Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries J. Am. Coll. Cardiol., August 1, 2001; 38(2): 569 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Badimon, G. Vilahur, S. Sanchez, and X. Duran Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I16 - I22. [Abstract] [PDF]
|
|
|
|
 |
|
 F. De Lorenzo, A. Noorani, and V.V. Kakkar Current trends in the management of thromboembolic events QJM, April 1, 2001; 94(4): 179 - 185. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zoldhelyi, Z.-Q. Chen, H. S. Shelat, J. M. McNatt, and J. T. Willerson Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries PNAS, March 27, 2001; 98(7): 4078 - 4083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ebeling, C. Geczy, A. Nakagomi, and S. B. Freedman Monocyte Tissue Factor Induction by C-Reactive Protein and Relationship With Hormone Replacement Treatment Response Circulation, February 27, 2001; 103 (8): e49 - e49. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Rauch, J. I. Osende, V. Fuster, J. J. Badimon, Z. Fayad, and J. H. Chesebro Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences Ann Intern Med, February 6, 2001; 134(3): 224 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Neve, D. Corseaux, G. Chinetti, C. Zawadzki, J.-C. Fruchart, P. Duriez, B. Staels, and B. Jude PPAR{{alpha}} Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages Circulation, January 16, 2001; 103(2): 207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Minnema, R. J. G. Peters, R. de Winter, Y. P. T. Lubbers, S. Barzegar, K. A. Bauer, R. D. Rosenberg, C. E. Hack, and H. t. Cate Activation of Clotting Factors XI and IX in Patients With Acute Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2489 - 2493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Penn, M.-Z. Cui, A. L. Winokur, J. Bethea, T. A. Hamilton, P. E. DiCorleto, and G. M. Chisolm Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation Blood, November 1, 2000; 96(9): 3056 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Cherwek, M. B. Hopkins, M. J. Thompson, B. H. Annex, and D. A. Taylor Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H932 - H938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Schecter, B. Spirn, M. Rossikhina, P. L. A. Giesen, V. Bogdanov, J. T. Fallon, E. A. Fisher, L. M. Schnapp, Y. Nemerson, and M. B. Taubman Release of Active Tissue Factor by Human Arterial Smooth Muscle Cells Circ. Res., July 21, 2000; 87(2): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ragni, P. Golino, P. Cirillo, A. Scognamiglio, O. Piro, N. Esposito, C. Battaglia, F. Botticella, P. Ponticelli, L. Ramunno, et al. Endogenous Tissue Factor Pathway Inhibitor Modulates Thrombus Formation in an In Vivo Model of Rabbit Carotid Artery Stenosis and Endothelial Injury Circulation, July 4, 2000; 102(1): 113 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Golino, M. Ragni, P. Cirillo, A. Scognamiglio, A. Ravera, C. Buono, A. Guarino, O. Piro, C. Lambiase, F. Botticella, et al. Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1507 - H1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakagomi, S. B. Freedman, and C. L. Geczy Interferon-{gamma} and Lipopolysaccharide Potentiate Monocyte Tissue Factor Induction by C-Reactive Protein : Relationship With Age, Sex, and Hormone Replacement Treatment Circulation, April 18, 2000; 101(15): 1785 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arnaud, V. Barbalat, V. Nicaud, F. Cambien, A. Evans, C. Morrison, D. Arveiler, G. Luc, J.-B. Ruidavets, J. Emmerich, et al. Polymorphisms in the 5' Regulatory Region of the Tissue Factor Gene and the Risk of Myocardial Infarction and Venous Thromboembolism : The ECTIM and PATHROS Studies Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Schecter, T. M. Calderon, A. B. Berman, C. M. McManus, J. T. Fallon, M. Rossikhina, W. Zhao, G. Christ, J. W. Berman, and M. B. Taubman Human Vascular Smooth Muscle Cells Possess Functional CCR5 J. Biol. Chem., February 25, 2000; 275(8): 5466 - 5471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Napoleone, A. Di Santo, M. Camera, E. Tremoli, and R. Lorenzet Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes Circ. Res., February 4, 2000; 86(2): 139 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ambrose and G. Dangas Unstable Angina: Current Concepts of Pathogenesis and Treatment Arch Intern Med, January 10, 2000; 160(1): 25 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Kojima, H Nonogi, Y Miyao, S Miyazaki, Y Goto, A Itoh, S Daikoku, T Matsumoto, I Morii, and C Yutani Is preinfarction angina related to the presence or absence of coronary plaque rupture? Heart, January 1, 2000; 83(1): 64 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schonbeck, F. Mach, G. K. Sukhova, M. Herman, P. Graber, M. R. Kehry, and P. Libby CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells Am. J. Pathol., January 1, 2000; 156(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Z. Cui, M. S. Penn, and G. M. Chisolm Native and Oxidized Low Density Lipoprotein Induction of Tissue Factor Gene Expression in Smooth Muscle Cells Is Mediated by Both Egr-1 and Sp1 J. Biol. Chem., November 12, 1999; 274(46): 32795 - 32802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Soejima, H. Ogawa, H. Yasue, K. Kaikita, K. Takazoe, K. Nishiyama, K. Misumi, S. Miyamoto, M. Yoshimura, K. Kugiyama, et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction J. Am. Coll. Cardiol., October 1, 1999; 34(4): 983 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Becker, F. A. Spencer, Y. Li, S. P. Ball, Y. Ma, T. Hurley, and J. Hebert Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: Potential mechanisms for heightened prothrombotic potential J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1020 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aikawa, S. J. Voglic, S. Sugiyama, E. Rabkin, M. B. Taubman, J. T. Fallon, and P. Libby Dietary Lipid Lowering Reduces Tissue Factor Expression in Rabbit Atheroma Circulation, September 14, 1999; 100(11): 1215 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. St. Pierre, L.-Y. Yang, K. Tamirisa, D. Scherrer, P. De Ciechi, P. Eisenberg, E. Tolunay, and D. Abendschein Tissue Factor Pathway Inhibitor Attenuates Procoagulant Activity and Upregulation of Tissue Factor at the Site of Balloon-Induced Arterial Injury in Pigs Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2263 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Arbustini, B Dal Bello, P Morbini, A P Burke, M Bocciarelli, G Specchia, and R Virmani Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction Heart, September 1, 1999; 82(3): 269 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Soejima, H. Ogawa, H. Yasue, K. Kaikita, K. Nishiyama, K. Misumi, K. Takazoe, Y. Miyao, M. Yoshimura, K. Kugiyama, et al. Heightened Tissue Factor Associated With Tissue Factor Pathway Inhibitor and Prognosis in Patients With Unstable Angina Circulation, June 8, 1999; 99(22): 2908 - 2913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Duscha, W. E. Kraus, S. J. Keteyian, M. J. Sullivan, H. J. Green, F. H. Schachat, A. M. Pippen, C. A. Brawner, J. M. Blank, and B. H. Annex Capillary density of skeletal muscle: A contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1956 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Ge, F Chirillo, J Schwedtmann, G Görge, M Haude, D Baumgart, V Shah, C von Birgelen, S Sack, H Boudoulas, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound Heart, June 1, 1999; 81(6): 621 - 627. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Badimon, M. Lettino, V. Toschi, V. Fuster, M. Berrozpe, J. H. Chesebro, and L. Badimon Local Inhibition of Tissue Factor Reduces the Thrombogenicity of Disrupted Human Atherosclerotic Plaques : Effects of Tissue Factor Pathway Inhibitor on Plaque Thrombogenicity Under Flow Conditions Circulation, April 13, 1999; 99(14): 1780 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Penn, C. V. Patel, M.-Z. Cui, P. E. DiCorleto, and G. M. Chisolm LDL Increases Inactive Tissue Factor on Vascular Smooth Muscle Cell Surfaces : Hydrogen Peroxide Activates Latent Cell Surface Tissue Factor Circulation, April 6, 1999; 99(13): 1753 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J.-M. Freyssinet, and A. Tedgui Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques : A Role for Apoptosis in Plaque Thrombogenicity Circulation, January 26, 1999; 99(3): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Engelmann, S. Zieseniss, K. Brand, S. Page, A. Lentschat, A. J. Ulmer, and E. Gerlach Tissue Factor Expression of Human Monocytes Is Suppressed by Lysophosphatidylcholine Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Corseaux, T. Le Tourneau, I. Six, M. D. Ezekowitz, E. P. Mc Fadden, T. Meurice, P. Asseman, C. Bauters, and B. Jude Enhanced Monocyte Tissue Factor Response After Experimental Balloon Angioplasty in Hypercholesterolemic Rabbit: Inhibition With Dietary L-Arginine Circulation, October 27, 1998; 98(17): 1776 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|